ArsenalBio
Suchismita Mohanty, Ph.D. has a strong background in in vivo modeling, drug development, and immuno-oncology research. With experience ranging from postdoctoral research to leading teams in companies like ArsenalBio and Kenjockety Biotechnology, they specialize in adoptive cell therapies, biologics, and anti-tumor targets in drug resistant cancers. Their expertise includes designing experiments, managing protocols, and conducting efficacy and toxicity studies in fast-paced environments.